Vitamin B status and cognitive performance in preclinical and clinical Alzheimer's disease: Data from the Kungsholmen Project

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 1, 2007, Pages 23-31

  Wahlin, Åke ^a,b   Fahlander, Kjell ^b   Robins Wahlin, Tarja Brita ^c   Bunce, David ^d   Bäckman, Lars ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b AGING RESEARCH CENTER   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Cognition; Comorbidity; Dementia; Folate; Population based; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; VITAMIN B GROUP;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEPTH PERCEPTION; EPISODIC MEMORY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; VERBAL HOSTILITY; VERBAL MEMORY; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; COMORBIDITY; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PERCEPTUAL DISORDERS; POPULATION SURVEILLANCE; RECOGNITION (PSYCHOLOGY); RISK FACTORS; SPACE PERCEPTION; VISUAL PERCEPTION; VITAMIN B DEFICIENCY;

EID: 37349024783     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111129     Document Type: Article

References (84)

1. Calvaresi E, Bryan J: B vitamins, cognition, and aging: a review. J Gerontol Psych Sci 2001;56B:P327-P339.
2. Gonzáles-Gross M, Marcos A, Pietrzik K: Nutrition and cognitive impairment in the elderly. Br J Nutr 2001;86:313-321.
3. Nourhashémi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H, Grand A, Pous J, Vellas B, Albarède J-L: Alzheimer disease: protective factors. Am J Clin Nutr 2000;71:643S-649S.
4. Reynish W, Andrieu S, Nourhashémi F, Vellas B: Nutritional factors and Alzheimer's disease. J Gerontol Med Sci 2001;56A:M675-M680.
5. Selhub J, Bagley LC, Miller J, Rosenberg IH: B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71:614S-620S.
6. Argyriadou S, Vlachonikolis I, Melisopoulou H, Katachanakis K, Lionis C: In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece. BMC Fam Pract 2001;2:5 (on-line serial). http://www.biomedcentral.com/1471-2296/2/5 (October 25).
7. 12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatr 1990;27:125-137.
8. Ebly EM, Schaefer JP, Campbell NRC, Hogan DB: Folate status, vascular disease and cognition in elderly Canadians. Age Ageing 1998;27:485-491.
9. Franchi F, Baio G, Bolognesi AG, Bonassi R, Emiliani S, Gobbi G, Luchetti L, Zurla L: Deficient folate nutritional status and cognitive performances: results from a retrospective study in male elderly inpatients in a geriatric department. Arch Gerontol Geriatr 2001;33:145-150.
10. Goodwin JS, Goodwin JM, Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. J Am Med Assoc 1983;249:2917-2921.
11. 12 and folate levels on episodic memory functioning: a population-based study on healthy very old adults. Biol Psychiatry 1999;45:1472-1480.
12. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ: Nutritional status and cognitive functioning in a normally aging sample: a 6-year reassessment. Am J Clin Nutr 1997;65:20-29.
13. 12, C and folate concentrations in the New Mexico Elder Health Survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000;19:68-76.
14. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
15. Ortega RM, Manas LR, Andres P, Gaspar MJ, Agudo RR, Jiminez A, Pasqual T: Functional and psychic deterioration in elderly people may be aggravated by folate deficiency. J Nutr 1996;126:1192-1199.
16. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T: Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997;66:803-809.
17. 6, folate and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-314.
18. 12 and folate status on cognitive functioning in very old age. Biol Psychol 2001;56:247-265.
19. 12 and folate status on episodic memory performance in very old age: a population-based study. Psychol Aging 1996;11:487-496.
20. 12 and behavioral and psychological symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:415-418.
21. Nilsson K, Gustafson L, Hultberg B: The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 2000;46:691-696.
22. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. 12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr Scand 1992;86:301-305.
24. Sommer BR, Wolkowitz OM: RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry 1988;24:352-354.
25. 12 levels in elderly patients with progressive dementia. Am J Geriatr Psychiatry 2002;10:321-327.
26. Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G: Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev 2000;121:251-261.
27. Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Bäckman L: Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 1997;19:245-260.
28. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST: Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology 2000;55:1863-1869.
29. 12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998;55:1449-1455.
30. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 2002;346:476-483.
31. 12 and folate in relation to the development of Alzheimer's disease. Neurology 2001;56:1188-1194.
32. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR: Serum folate and the severity of atrophy of the neocortex in Alzheimer's disease: findings from the Nun Study. Am J Clin Nutr 2000;71:993-998.
33. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H: Total serum homocysteine in senile dementia of Alzheimer's disease. Int J Geriatr Psychiatry 1998;13:235-239.
34. 12 in Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:133-137.
35. Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattström L, Lindgren A, Israelsson B, Hultberg B: Hyperhomocysteinaemia - a common finding in a psychogeriatric population. Eur J Clin Invest 1996;26:853-859.
36. Basun H, Fratiglioni L, Winblad B: Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study. J Am Geriatr Soc 1994;42:132-136.
37. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W, Dejaeger E: Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol Med Sci 1997;52A:M76-M79.
38. Bäckman L, Small BJ, Wahlin Å, Larsson M: Cognitive functioning in very old age;in Craik FIM, Salthouse TA (eds): Handbook of Cognitive Aging, 2nd ed. Mahwah, Erlbaum, 2000, pp 499-558.
39. Hill RD, Bäckman L, Wahlin Å, Winblad B: Visuospatial performance in very old demented persons: an individual difference analysis. Dementia 1995;6:49-54.
40. Rubin EH, Storandt M, Miller JP, Grant EA, Kinscherf DA, Morris JC, Berg L: Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type. Arch Neurol 1993;50:380-383.
41. Teri L, McCurry SM, Edland SD, Kukull WA, Larsson EB: Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol Med Sci 1995;50:49-55.
42. Burns A, Jacoby R, Levy R: Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc 1991;39:39-45.
43. Katzman R, Brown T, Thal LJ, Fuld P, Aronson M, Butters N, Klauber MR, Wiederholt W, Pay M, Renbing X, Ooi WL, Hofstetter R, Terry RD: Comparison of annual change of mental status scores in four independent studies of patients with Alzheimer's disease. Ann Neurol 1983;24:384-389.
44. Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW: Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol 1993;50:757-760.
45. Teri L, Hughes JP, Larson EB: Cognitive deterioration in Alzheimer's disease: behavioral and health factors. J Gerontol Psychol Sci 1990;45:58-63.
46. Bäckman L, Hassing L, Forsell Y, Viitanen M: Episodic remembering in a population-based sample of nonagenarians: does major depression exacerbate the memory deficits seen in Alzheimer's disease? Psychol Aging 1996;11:649-657.
47. Berger A-K, Fahlander K, Wahlin Å, Bäckman L: Negligible effects of depression on verbal and spatial performance in Alzheimer's disease. Dement Geriatr Cogn Disord 2002;13:1-7.
48. Fahlander K, Berger A-K, Wahlin Å, Bäckman L: Depression does not aggravate the episodic memory deficits associated with Alzheimer's disease. Neuropsychology 1999;13:532-538.
49. Wahlin Å, Nilsson E, Fastbom J: Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death. Neuropsychology 2002;16:208-216.
50. Small BJ, Bäckman L: Predictors of longitudinal changes in memory, visuospatial, and verbal functioning in very old demented adults. Dement Geriatr Cogn Disord 1998;9:258-266.
51. Fratiglioni L, Viitanen M, Bäckman L, Sandman P-O, Winblad B: Occurrence of dementia in advanced age: the study design of the Kungsholmen project. Neuroepidemiology 1992;11(suppl 1):29-36.
52. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-III-R ed 3, rev. Washington, American Psychiatric Association, 1987.
53. 12 and folic acid in serum evaluated. Clin Chem 1982;28:2161-2165.
54. Tulving E, Colotla V: Free recall of trilingual lists. Cogn Psychol 1970;1:86-98.
55. Snodgrass JG, Corwin J: Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 1988;117:34-50.
56. Wechsler D: Wechsler Adult Intelligent Scale Revised. Manual. New York, Psychological Corporation, 1981.
57. Christensen A-L: Lurias Neuropsychological Investigation. Copenhagen, Munksgaard, 1984.
58. Statistiska Centralbyrån: Befolkningens utbildningsnivå (Level of Education for the Inhabitants). Örebro, Statistiska Centralbyrån, 1985.
59. Bernard MA, Nakonezny PA, Kashner TM: The effect of vitamin B12 deficiency on older veterans and its relationship to health. J Am Geriatr Soc 1998;46:1199-1206.
60. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ: Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2003;75:908-913.
61. Kalaria RN, Ballard C: Overlap between pathology of Alzheimer's disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13:S115-S123.
62. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-1356.
63. Marra C, Bizzarro A, Danielee A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C: Apolipoprotein E e4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patterns. Dement Geriatr Cogn Disord 2005;18:125-131.
64. Aerssens J, Raeymaekers P, Lilienfeld S, Geerts H, Konings F, Parys W: APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:69-77.
65. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
66. Caselli RJ, Graff-Radford NR, Reiman EM, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN: Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology 1999;53:201-207.
67. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ: Cognitive change and the APOE e4 allele. Nature 2002;418:932.
68. Hofer SM, Christensen H, MacKinnon AJ, Korten AE, Jorm AF, Henderson AS, Easteal S: Changes in cognitive functioning associated with ApoE genotype in a community sample of older adults. Psychol Aging 2002;17:194-208.
69. Stahelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ: Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 1999;100:53-60.
70. Bunce D, Kivipelto M, Wahlin Å: Utilization of cognitive support and episodic free recall as a function of apolipoprotein E, vitamin B or folate in adults aged 75 years and older. Neuropsychology 2004;18:362-370.
71. Bunce D, Kivipelto M, Wahlin Å: Apolipoprotein E, B vitamins, and cognitive function in older adults. J Gerontol Psychol Sci 2005;60B:P41-P48.
72. Fox NC, Warrington EK, Sieffer AL, Agnew SK, Rossor MN: Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study. Brain 1998;121:1631-1639.
73. Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L: A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55:395-401.
74. Almkvist O, Fratiglioni L, Agüero-Torres H, Viitanen M, Bäckman L: Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. J Clin Exp Neuropsychol 1999;21:816-830.
75. Fahlander K, Wahlin Å, Almkvist O, Bäckman L: Cognitive functioning in Alzheimer's disease and vascular dementia: further evidence for similar patterns of deficits. J Clin Exp Neuropsychol 2002;24:734-744.
76. Shuttleworth EC, Huber SJ: The naming disorder of dementia of Alzheimer type. Brain Lang 1988;34:222-234.
77. Monsch AU, Bondi MW, Butters N, Salmon DP, Katzman R, Thal LJ: Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol 1992;49:1253-1258.
78. Chan AS, Butters N, Salmon DP: The deterioration of semantic networks in patients with Alzheimer's disease: a cross-sectional study. Neuropsychologia 1997;35:241-248.
79. Hodges JR, Patterson KE: Is semantic memory consistently impaired early in the course of Alzheimer's disease: diagnostic and neuroanatomical implications. Neuropsychologia 1995;33:441-459.
80. Small BJ, Viitanen M, Winblad B, Bäckman L: Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables. J Clin Exp Neuropsychol 1997;19:245-260.
81. Buchner A, Faul F, Erdfelder E, Power G: A priori, post-hoc, and compromise power analyses for the Macintosh (version 2.1.2) (computer program). Trier, University of Trier, 1997.
82. 12) handling: implication for therapy. Drug Aging 1998;12:277-292.
83. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population. Dement Geriatr Cogn Disord 1999;10:476-482.
84. Green R, Kinsella LJ: Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995;45:1435-1440.